Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$20.20 -0.30 (-1.46%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Restructuring Costs (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) recorded Restructuring Costs of $7.6 million in Q2 2026, up 642.2% from $1.02 million a year earlier and up 47.5% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Restructuring Costs (2017 - 2026) Analysis & Trends

On a TTM basis, Amneal Pharmaceuticals' Restructuring Costs came in at $15.37 million as of Jun 30, 2026, up 579.9% year-over-year; for FY2025, it came in at $4.21 million, up 78.7% from FY2024.

  • Annual Restructuring Costs has increased for three straight years, though with a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
  • Across earlier years, Restructuring Costs came in at $2.36 million in FY2024 (+34.6%), $1.75 million in FY2023 (+23.1%), $1.42 million in FY2022 (-82.5%) and $8.1 million in FY2021 (-10.0%).
  • The Q2 2026 figure is the highest quarterly Restructuring Costs since Q3 2019.
  • On a year-over-year basis, Restructuring Costs has increased for three consecutive quarters, with growth averaging 297.8% over the last eight quarters.
  • Peak year-over-year performance for Restructuring Costs in the last five years was growth of 802.5% in Q1 2026, against a decline of 98.5% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $5.15 million (Q1 2026), $2.47 million (Q4 2025) and $143,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Amneal Pharmaceuticals 6.55 Bn 5.82 Bn 334.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.60 Mn
Mar 31, 2026 5.15 Mn
Dec 31, 2025 2.47 Mn
Sep 30, 2025 143,000.00
Jun 30, 2025 1.02 Mn
Mar 31, 2025 571,000.00
Dec 31, 2024 493,000.00
Sep 30, 2024 172,000.00
Jun 30, 2024 220,000.00
Mar 31, 2024 1.47 Mn
Dec 31, 2023 114,000.00
Sep 30, 2023 1.04 Mn
Jun 30, 2023 82,000.00
Mar 31, 2023 510,000.00
Dec 31, 2022 109,000.00
Sep 30, 2022 581,000.00
Mar 31, 2022 731,000.00
Dec 31, 2021 7.31 Mn
Sep 30, 2021 425,000.00
Mar 31, 2021 363,000.00
API Access

Amneal Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=AMRX&period=max&api_key=YOUR_API_KEY